Company news

Gossamer Bio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Gossamer Bio Announces Participation in the Guggenheim Healthcare Talks Neuro/Immunology Day

November 13, 2019

Gossamer Bio Announces Third Quarter 2019 Financial Results

November 11, 2019

Gossamer Bio Announces Clinical Trial Collaboration Agreement With Merck to Evaluate GB1275 in Combination With KEYTRUDA® (Pembrolizumab) in Selected Advanced Solid Tumors

November 11, 2019

Gossamer Bio Announces Data Presentations at the American Heart Association Scientific Sessions 2019

November 10, 2019

Gossamer Bio Announces Data Presentations at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting 2019

November 7, 2019

Gossamer Bio Announces Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting

November 6, 2019

Gossamer Bio to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 12, 2019

November 4, 2019

Gossamer Bio Announces Participation in the 2019 Cantor Global Healthcare Conference

September 24, 2019

Gossamer Bio Announces the Departure of Dr. Otello Stampacchia from its Board of Directors

September 12, 2019

← Newer news releases

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 10 decks. Every deck is listed under its year.